MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


EARNINGS: Billington profit dives; Emmerson and Roquefort narrow loss

ALN

The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Billington Holdings PLC - The structural steel and construction safety solutions company - Revenue falls 28% to £41.8 million for the six months to the end of June from £57.9 million a year prior. Pretax profit plunges 64% to £1.7 million from £4.6 million. The firm declares no interim dividend, unchanged from the prior year. Billington expects results for 2025 to be below market expectations due to client-led contract delays and the associated timing of profit. It says 2026 remains in line with market expectations. ‘Following a strong performance by Billington in 2024 it is unfortunate that the market for structural steelwork and the construction industry more widely has, as a result of economic uncertainty and lack of consumer confidence, become increasingly subdued during the first half of 2025,’ says CEO Mark Smith. ‘The timing of profit recognition on certain significant contracts, as a consequence of client led project delays, will result in the recognition of margin later than was previously anticipated. We are optimistic that the market will see some recovery in 2026 as stability and increased confidence returns to the sector.’

----------

UIL Ltd - closed-end investment company - Reports NAV total return of 14.7% for year to June 30, compared with negative 15.3% a year prior. Share price total return 22.5%, versus negative 24.8% the year before. Net asset value per share rises to 179.41 pence from 164.04p. NAV discount at year end narrows to 34.2% from 36.9%. Revenue earnings per share improve to 11.91p from 10.15p. Declares total dividend of 8.00p, unchanged. Chair Stuart Bridges says the return was ‘particularly noteworthy given the ongoing economic and, more specifically, geopolitical challenges during this period.’

----------

Emmerson PLC - developer of the Khemisset potash mine in Morocco - Pretax loss narrows to $1.3 million from $1.6 million a year prior. Loss per share improves to 0.10 cents from 0.15 cents. Reports no revenue for the six months to June 30, unchanged from a year earlier. Administrative expenses fall to $936,000 from $1.5 million, while legal expenses rise to $1.0 million linked to arbitration proceedings with Morocco over the expropriation of the Khemisset Potash project. Cash balance at June 30 stands at $600,000. Company has secured up to $11.0 million in litigation funding to cover legal costs and working capital. Emmerson says it will ‘continue zealously to pursue’ claims seeking full compensation, with the project previously valued at $2.2 billion.

----------

Roquefort Therapeutics PLC - developing medicines in immunology and oncology sectors - Pretax loss narrows to £532,034 in the six months to the end of June from £702,781 a year prior. It reports no revenue for the year, unchanged from the previous year. Administrative expenses fall 36% to £347,750 from £541,171. The firm says it plans to pivot away from its existing focus on pre-clinical assets to more mature clinical stage assets by completing the proposed acquisition of Coiled USA. The enlarged entity, to be renamed Coiled Therapeutics PLC, will focus on advancing clinical trials for the AO-252 therapy. ‘During the period Roquefort Therapeutics announced a new strategic direction to refocus from pre-clinical assets towards clinical stage assets with a clearer path towards value creation and we are pleased to have identified Coiled Therapeutics from A2A Pharmaceuticals as our transformational acquisition. Our focus for the remainder of the year is to complete the proposed acquisition of Coiled Therapeutics, which will potentially set the company up with two clinical stage assets: AO-252 and STAT-6,’ says Chair Stephen West.

----------

Reabold Resources PLC - investor focused on developing strategic gas projects for European energy security - Reports pretax loss of £1.5 million in six months to June 30, narrowing from £2.0 million a year earlier. No revenue in either period. Loss per share narrows to 0.01 pence from 0.02p. Administrative expenses rise to £1.2 million from £1.0 million, partly reflecting consolidation of Rathlin Energy. Net cash at June 30 stands at £4.0 million, down from £6.3 million at December 31. Co-CEOs Sachin Oza and Stephen Williams say the period delivered ‘a number of exciting developments,’ citing progress in Italy’s Colle Santo gas project and further investment in West Newton.

----------

Tanfield Group PLC - passive investing company with 49% interest in producer of self-propelled, towable and push-around aerial lifts Snorkel International - Posts pretax loss of £540,000 for six months to June 30, widening from £97,000 a year prior, with no revenue in either period. Loss per share widens to 0.33 pence from 0.06p. Says higher legal and professional fees ahead of a December 2025 trial in ongoing US proceedings weighed on results. Cash at June 30 falls to £2.8 million from £3.2 million at December 31. Notes its 49% stake in Snorkel International remains valued at £19.1 million, with court ruling in May confirming Snorkel must pay around $25 million preferred interest before exercise of a call option. Board says it ‘will continue to vigorously defend its position whilst continuing to seek advice’ in the proceedings.

----------

ICG-Longbow Senior Secured UK Property Debt Investments Ltd - investor in UK real estate debt - Reports pretax profit of £49,140 for six months to July 31, swinging from £1.9 million loss a year earlier. Earnings per share are 0.04 pence versus 1.55p loss. Net asset value falls to £23.3 million from £32.9 million at January 31, with NAV per share down to 19.19p from 27.15p. Says two investments remain following sale of Affinity loan asset, which enabled an 8.00p per share return of capital in July. Southport hotel asset is under offer, while RoyaleLife portfolio is under new management ahead of formal marketing process. No dividend declared. Chair Jack Perry says the board remains focused on protecting and enhancing shareholder value, adding: ‘The bard remains focused on protecting and enhancing shareholder value and delivering returns of capital in the best manner possible.’

----------

Ecofin US Renewables Infrastructure Trust PLC - invests in renewable energy and sustainable infrastructure assets located in US - Narrows half-year loss of $5.7 million in the six months to June 30, versus $25.9 million a year prior. Net asset value per share falls to 40.6 cents at June-end from 44.7 cents at December 31. No dividend declared, after 0.7 cents a year earlier, as company focuses on realisation of remaining assets under managed wind-down. Chair says board remains focused on orderly asset sales and capital return to shareholders.

----------

Ashington Innovation PLC - special purpose acquisition company - Reports no revenue for the six months to June 30, unchanged from a year prior. Pretax loss narrows to £117,478 from £202,036. Loss per share improves to 0.16 pence from 0.32 pence. Company says it remains in early stage discussions with a number of potential acquisition targets in the fintech and deep technology sectors.

----------

Copyright 2025 Alliance News Ltd. All Rights Reserved.